| Date Filed | Type | Description |
| 01/27/2017 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 12.3% stake in FORTRESS BIOTECH, INC. |
| 01/27/2016 |
SC 13D
| ROSENWALD LINDSAY A MD reports a 13.3% stake in FORTRESS BIOTECH, INC. |
| 01/05/2015 |
SC 13D
| ROSENWALD LINDSAY A MD reports a 23.2% stake in CB Pharma Acquisition Corp. |
| 02/13/2014 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 14.1% stake in Coronado Biosciences, Inc. |
| 02/14/2013 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 14.7% stake in Coronado Biosciences, Inc. |
| 04/02/2012 |
SC 13G
| ROSENWALD LINDSAY A MD reports a 10% stake in Ventrus Biosciences, Inc. |
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/09/2010 |
SC 13G
| ROSENWALD LINDSAY A MD reports a 5% stake in CorMedix Inc., a Delaware corporation |
| 03/11/2010 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 10% stake in Manhattan Pharmaceuticals, Inc. |
| 06/02/2009 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/03/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/03/2009 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 3.5% stake in NovaDel Pharma Inc. |
| 02/03/2009 |
SC 13G
| ROSENWALD LINDSAY A MD reports a 5.2% stake in NovaDel Pharma Inc. |
| 02/03/2009 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 9.9% stake in VioQuest Pharmaceuticals, Inc. |
| 02/03/2009 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 5.2% stake in NovaDel Pharma Inc. |
| 02/03/2009 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 16.5% stake in COUGAR BIOTECHNOLOGY, INC. |
| 02/13/2008 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 5.9% stake in Manhattan Pharmaceuticals, Inc. |
| 02/13/2008 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 3.6% stake in ZIOPHARM Oncology, Inc. |
| 02/13/2008 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 14.2% stake in NovaDel Pharma Inc. |
| 02/13/2008 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 3.4% stake in Javelin Pharmaceuticals, Inc.. |
| 02/13/2008 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 6.7% stake in VioQuest Pharmaceuticals, Inc. |
| 02/13/2008 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 10.9% stake in INNOVIVE PHARMACEUTICALS, INC. |
| 02/13/2008 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 16.6% stake in COUGAR BIOTECHNOLOGY, INC. |
| 11/07/2007 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |
| 03/09/2007 |
SC 13G/A
|
SEC Filing in the EDGAR database
|
| 02/13/2007 |
SC 13G/A
|
SEC Filing in the EDGAR database
|
| 02/13/2007 |
SC 13G/A
|
SEC Filing in the EDGAR database
|
| 02/13/2007 |
SC 13G
|
SEC Filing in the EDGAR database
|
| 02/13/2007 |
SC 13G/A
|
SEC Filing in the EDGAR database
|
| 02/13/2007 |
SC 13G/A
|
SEC Filing in the EDGAR database
|
| 07/10/2006 |
SC 13D
| ROSENWALD LINDSAY A MD reports a 0% stake in |
| 05/24/2006 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 0% stake in |
| 05/16/2006 |
SC 13D/A
| ROSENWALD LINDSAY A MD reports a 0% stake in |
| 04/24/2006 |
SC 13G
| ROSENWALD LINDSAY A MD reports a 0% stake in |
|